Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.96M | 19.77M | 27.45M | 33.10M | 8.66M |
| Total Receivables | 139.90K | 134.60K | 238.50K | 228.90K | 105.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.30M | 2.93M | 913.30K | 1.11M | 1.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 91.40M | 22.83M | 28.61M | 34.44M | 9.89M |
|
|
|||||
| Total Current Assets | 91.40M | 22.83M | 28.61M | 34.44M | 9.89M |
| Net Property, Plant & Equipment | 851.60K | 688.30K | 546.50K | 424.90K | 456.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 97.60K | 77.80K | 80.20K | 80.80K | 18.40K |
| Total Assets | 92.35M | 23.60M | 29.23M | 34.94M | 10.36M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | 3.03M | -- |
| Total Accrued Expenses | 3.71M | 2.55M | 2.10M | 3.01M | 2.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 76.10K | 35.10K | 52.80K | 71.90K | 78.80K |
| Total Finance Division Other Current Liabilities | 28.10K | 28.80K | 45.20K | 20.70K | 22.30K |
| Total Other Current Liabilities | 28.10K | 28.80K | 45.20K | 20.70K | 22.30K |
| Total Current Liabilities | 3.81M | 2.62M | 2.20M | 3.10M | 2.37M |
|
|
|||||
| Total Current Liabilities | 3.81M | 2.62M | 2.20M | 3.10M | 2.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 94.50K | -- | -- | -- | 14.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | -- |
| Total Liabilities | 3.91M | 2.62M | 2.20M | 3.10M | 2.39M |
|
|
|||||
| Common Stock & APIC | 214.49M | 140.14M | 138.79M | 136.86M | 135.81M |
| Retained Earnings | -152.87M | -146.51M | -137.77M | -131.00M | -123.49M |
| Treasury Stock & Other | -3.30M | -2.79M | -4.12M | -4.16M | -2.79M |
| Total Common Equity | 58.32M | -9.15M | -3.10M | 1.70M | 9.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 31.71M | 31.71M | 31.71M | 31.71M | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 31.71M | 31.71M | 31.71M | 31.71M | -- |
|
|
|||||
| Total Common Equity | 58.32M | -9.15M | -3.10M | 1.70M | 9.52M |
| Total Preferred Equity | 31.71M | 31.71M | 31.71M | 31.71M | -- |
| Total Minority Interest | -1.59M | -1.58M | -1.57M | -1.57M | -1.54M |
| Total Equity | 88.44M | 20.98M | 27.03M | 31.84M | 7.98M |
|
|
|||||